| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Renz Justin A | Chief Financial Officer | C/O ARDELYX, INC., 400 FIFTH AVENUE, SUITE 210, WALTHAM | /s/ Elizabeth Grammer, Attorney-in-Fact for Justin Renz | 22 May 2025 | 0001466562 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARDX | Common Stock | Sale | $29,460 | -7,218 | -1.7% | $4.08 | 416,089 | 20 May 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. |
| F2 | Reflects the adjusted total which includes the purchase of 659 shares under the Ardelyx Employee Stock Purchase Plan in February 2025. |